Publication: Is predicting the risk of incident diabetes useful in patients with cardiovascular disease?
Loading...
Identifiers
Publication date
Authors
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Oxford University Press
Metrics
Export
Abstract
Description
Dr Bueno receives research funding from the European Union (EU4H-2022-JA-03), Instituto de Salud Carlos III, Spain (FORTALECE program, PI21/01572), Sociedad Española de Cardiología, AstraZeneca, Boehringer Ingelheim, Janssen, and Novartis; and has received in the past consulting/speaking fees from
Astra-Zeneca, Novartis, Novo Nordisk and Organon.
Keywords
MeSH Terms
DeCS Terms
Bibliographic citation
Eur J Prev Cardiol. 2024 Oct 10;31(14):1679-1680.